Rett syndrome is a devastating rare genetic childhood disorder primarily affecting girls. Merely 1 out of 10,000 girls are ...

For the first time, chemists have discovered a unique way to control and modify a type of compound widely used in medicines, ...

In today's episode of *Blueprint Explosive Exclusive* with anchor Meghna Deka, the discussion revolves around the tragic ...

This research could represent the first documented case of paracetamol production from plastic waste using E. coli bacteria.

It can produce extended-release tablets using both wet and dry granulation techniques, and design drug delivery systems for poorly soluble compounds. PLD Pharma Services has the capacity to produce up ...

Falcipains (FPs) are hemoglobinases of Plasmodium falciparum that are validated targets for the development of antimalarial chemotherapy. A combined ligand- and structure-based virtual screening of ...

This article is cited by 17 publications. Jamie Anne Lugtu-Pe, Bing Ying Lin, Kuan Chen, Alireza Ghaffari, Anil Kane, Xiao Yu Wu. Tailoring Release Profiles of BCS Class II Drugs Using Controlled ...

The FDA didn’t routinely test the medications for quality problems or use its vast repository of drug-related complaints to proactively track whether they were harming the people who relied on them.

Many drug targets are localized to particular subcellular compartments, yet current drug design strategies are focused on bioavailability and tissue targeting and rarely address drug delivery to ...

The US Food and Drug Administration (FDA) has granted approval to a tablet formulation of BeOne Medicines’ targeted cancer drug Brukinsa (zanubrutinib). The company formerly known as BeiGene announced ...